This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Japanese privacy commission's caution about OpenAI indicates shift toward more scrutiny

By Sachiko Sakamaki ( June 9, 2023, 09:08 GMT | Comment) -- The Japanese privacy commission is generally known to be more of a follower than a trailblazer when it comes to going after technology giants. But last week, it became the world’s second regulator to take action against OpenAI, the provider of artificial intelligence chatbot ChatGPT, although the guidance it issued was only a slap on the hand. While experts have mixed views about the caution to the US company, the regulator’s action seems to indicate a shift in Japan's approach that will see more scrutiny of generative artificial intelligence for better governance. The Japanese privacy commission is generally known to be more of a follower than a trailblazer when it comes to going after technology giants. But last week, it became the world’s second regulator to take action against OpenAI, the provider of artificial intelligence chatbot ChatGPT, although the guidance it issued was only a slap on the hand....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login